Patients with CML need to begin treatment once they are diagnosed.
慢粒患者在确诊后就需要开始治疗。
Patients with CML should talk with their family, friends and caregivers about how they feel.
慢粒患者应该同家人、朋友及护理人员诉说自己的感受。
The study shows that abnormalities of erythrocyte membrane skeleton may be one of the factors of anemia associated with CML.
结果提示CML红细胞膜骨架的异常可能为CML病人严重贫血的原因之一。
Objective To insure success of unrelated-donor peripheral blood stem cell transplantation (URD-PBSCT) for patient with CML at the first time in chongqing.
目的确保重庆市首例非血缘异基因外周血干细胞移植(URD - PBSCT)治疗慢性粒细胞白血病成功。
Conclusions: it is the first report to describe the condition of thymic recent output function and peripheral t cells immune function in patients with CML.
结论：本研究首先提供了CML患者胸腺和外周的t细胞免疫功能状态的情况。
Family, friends and caregivers can often help you cope with what lies ahead. Also, patients with CML may get to know one another. These friendships help too.
家人，朋友和护理人员会经常帮助患者应对将要面临的困难，同时，慢粒患者之间可以相互了解。这种友谊也能给患者带来帮助。
A useful test to help distinguish this disease is the leukocyte alkaline phosphatase (LAP) score, which should be low with CML and high with a leukemoid reaction.
须与类白血病相鉴别，可用的检测是粒细胞碱性磷酸酶(LAP)，慢性髓性白血病较低而类白血病反应较高。
The inactivation of P53 is associated with the acute transformation phase and development of CML.
P 53基因失活与慢性粒细胞白血病的急变、病情进展密切相关。
Objective To investigate the association of the programmed cell death (PCD) regulating proteins with the acute transformation of chronic myelogenous leukemia (CML).
目的了解细胞程序死亡(PCD)与慢性髓细胞性白血病(CML)急变的关系。
Objective To investigate that whether the immuno-modulatory capacity is intact in CML patients bone marrow derived MSCs and what are the differences compare with those from normal donors.
目的研究慢性粒细胞白血病（CML）骨髓来源的肿瘤干细胞的免疫学特征，比较其与正常人来源的间充质干细胞（MSC）是否存在免疫功能的异常。
The Philadelphia chromosome (universally present in CML) is lacking in patients with leukemoid reactions.
费城染色体(一般出现在CML)在白血病样反应中一般不出现。
The stability of the CML with pinning controlling is analyzed with linear analysis, and the coupled gradient effect on controlling efficiency is analyzed also.
考虑非对称耦合映象格子的控制问题，用线性分析的方法分析了在钉扎控制下系统的稳定性，同时还分析了耦合的非对称性对控制效率的影响。
Depression is an illness. It should be treated even when a person is being treated for CML. Treatment for depression has benefits for people living with cancer.
抑郁是一种疾病。即使病人正在接受慢粒的治疗，也应对其的抑郁进行治疗。这对患有癌症的病人有好处。
Recently, elevated IL-18 levels were found in serum from some leukemia patients, especially those with acute lymphocytic leukemia (all) and chronic myeloid leukemia (CML).
近来，研究发现急性淋巴细胞白血病(all)和慢性粒细胞白血病(CML)患者血清中il - 18水平高于正常人。
CML starts with a change to a single stem cell. A stem cell is a type of cell found in marrow that makes red cells, white cells and platelets.
慢粒的发病源于单个干细胞的变异。干细胞存在于骨髓中，可以分化成红细胞、白细胞和血小板。
The structures of oligosaccharides from crotalaria mucronata lectin(CML) with human A blood group specificity were studied to elucidate the molecular recognition mechanism of lectin.
为了探讨凝集素的分子识别机制，对A型血专一性凝集素———野花生豆凝集素的寡糖链结构进行了研究。
Objective to detect the ABL point mutations in chronic myeloid leukemia (CML) patients treated with imatinib by denaturing high-performance liquid chromatography (DHPLC).
目的应用变性高效液相色谱(DHPLC)检测伊马替尼治疗后慢性髓性白血病(CML)患者ABL激酶区点突变。
Objective To measure the serum level of interleukin-18(IL-18) in patients with chronic myelocytic leukemia (CML).
目的：检测慢性粒细胞白血病（CML）患者血清IL-18水平。
Conclusion CML consists of a group of diseases with high heterogeneity, and the prognoses of the patients mostly depend on the malignancy of the tumor.
结论慢性期CML是一组高度异质性疾病，肿瘤生物学恶性的高低决定了病人的预后。
Conclusion The combination regimen of HHT and Ara cis effective and economical in patient with late chronic-phase chronic myelogenous leukemia(CML).
结论高三尖杉酯碱联合低剂量阿糖胞苷治疗慢粒白血病急变简便，经济，有效。
The nuclear volume of the positive tumor cell or lymphocyte with PC10 immunostaining may be also useful in differentiating CML from CLI.
PC10免疫染色阳性瘤细胞或淋巴细胞的核容积也有助于鉴别CML与CLI。
Children with a family member who has CML may need special attention. They may feel bad that their family member is sick. They may be sad or angry that their parents are not around as much.
应给与家人中有患有慢粒患者的小孩格外的关注。他们对家人的生病会感到很糟糕。他们可能会因为父母不常在身边而感到难过或生气。
A team of researchers from the U. s. and Europe, including the drug's creator, Brian Druker, MD, followed 454 patients with chronic-phase CML taking imatinib for more than six years.
包括药物的发明者BrianDruker博士在内的一个由来自美国和欧洲的研究人员组成的团队跟踪研究了454位慢性粒细胞性白血病慢性期患者，这些患者使用伊马替尼已经超过6年。
A team of researchers from the U. s. and Europe, including the drug's creator, Brian Druker, MD, followed 454 patients with chronic-phase CML taking imatinib for more than six years.
包括药物的发明者BrianDruker博士在内的一个由来自美国和欧洲的研究人员组成的团队跟踪研究了454位慢性粒细胞性白血病慢性期患者，这些患者使用伊马替尼已经超过6年。
应用推荐